The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response today awarded a $12 million contract to support advanced development of an experimental drug for Ebola. In non-human primate studies, the drug (BCX4430) was effective against the Ebola and Marburg viruses, the agency said.